Buys | $64,200 | 1 | 3 |
Sells | $6,355,644 | 29 | 97 |
Smiley Joshua L | See Remarks | 1 | $64,200 | 2 | $103,719 | $-39,519 |
GAYNOR RICHARD | director | 0 | $0 | 1 | $48,750 | $-48,750 |
Chen Yajing | Chief Financial Officer | 0 | $0 | 6 | $79,729 | $-79,729 |
Chen Kai-Xian | director | 0 | $0 | 1 | $133,455 | $-133,455 |
Reinhart Harald | See Remarks | 0 | $0 | 3 | $194,650 | $-194,650 |
Amado Rafael | See Remarks | 0 | $0 | 4 | $328,325 | $-328,325 |
Lis William | director | 0 | $0 | 2 | $674,785 | $-674,785 |
Edmondson Frazor Titus III | Chief Legal Officer | 0 | $0 | 7 | $1.04M | $-1.04M |
Du Ying | Chairperson & CEO | 0 | $0 | 5 | $3.99M | $-3.99M |
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. It also develops Odronextamab to treat follicular …
Over the last 12 months, insiders at Zai Lab Limited have bought $64,200 and sold $6.36M worth of Zai Lab Limited stock.
On average, over the past 5 years, insiders at Zai Lab Limited have bought $222,127 and sold $49.29M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Smiley Joshua L (See Remarks) — $64,200.
The last purchase of 3,000 shares for transaction amount of $64,200 was made by Smiley Joshua L (See Remarks) on 2024‑05‑13.
2025-03-03 | Sale | Du Ying | Chairperson & CEO | 50,000 0.4786% | $32.44 | $1.62M | +11.66% | |
2025-02-28 | Sale | Du Ying | Chairperson & CEO | 50,000 0.4548% | $34.47 | $1.72M | +2.25% | |
2025-02-28 | Sale | Lis William | director | 15,000 0.1305% | $32.98 | $494,700 | +2.25% | |
2025-02-28 | Sale | Edmondson Frazor Titus III | Chief Legal Officer | 14,544 0.1266% | $32.98 | $479,661 | +2.25% | |
2024-12-31 | Sale | Amado Rafael | See Remarks | 7,583 0.007% | $26.28 | $199,289 | +5.12% | |
2024-11-04 | Sale | Chen Yajing | Chief Financial Officer | 167 0.0002% | $30.66 | $5,121 | -11.28% | |
2024-10-02 | Sale | Chen Yajing | Chief Financial Officer | 301 0.0003% | $25.40 | $7,645 | +7.11% | |
2024-09-03 | Sale | GAYNOR RICHARD | director | 2,500 0.0025% | $19.50 | $48,750 | +38.84% | |
2024-08-19 | Sale | Edmondson Frazor Titus III | Chief Legal Officer | 1,924 0.0019% | $16.95 | $32,620 | +57.00% | |
2024-08-16 | Sale | Smiley Joshua L | See Remarks | 4,352 0.0045% | $16.67 | $72,561 | +56.15% | |
2024-08-15 | Sale | Chen Yajing | Chief Financial Officer | 422 0.0004% | $16.06 | $6,779 | +60.06% | |
2024-08-12 | Sale | Amado Rafael | See Remarks | 3,115 0.0031% | $16.20 | $50,463 | +63.55% | |
2024-07-01 | Sale | Du Ying | Chairperson & CEO | 7,013 0.0069% | $17.48 | $122,573 | +51.24% | |
2024-07-01 | Sale | Chen Kai-Xian | director | 7,750 0.0075% | $17.22 | $133,455 | +51.24% | |
2024-07-01 | Sale | Lis William | director | 10,397 0.0102% | $17.32 | $180,085 | +51.24% | |
2024-06-26 | Sale | Du Ying | Chairperson & CEO | 23,939 0.0242% | $17.90 | $428,532 | +44.96% | |
2024-06-26 | Sale | Reinhart Harald | See Remarks | 7,431 0.0075% | $17.90 | $133,022 | +44.96% | |
2024-06-26 | Sale | Edmondson Frazor Titus III | Chief Legal Officer | 5,062 0.0051% | $17.90 | $90,615 | +44.96% | |
2024-06-26 | Sale | Chen Yajing | Chief Financial Officer | 2,154 0.0022% | $17.90 | $38,559 | +44.96% | |
2024-05-14 | Sale | Edmondson Frazor Titus III | Chief Legal Officer | 10,000 0.01% | $21.33 | $213,346 | +15.31% |
Smiley Joshua L | See Remarks | 43232 0.3993% | $1.65M | 4 | 2 | <0.0001% |
WIRTH PETER | director | 0 0% | $0 | 1 | 1 | <0.0001% |
$14,527,743 | 76 | 38.40% | $447.93M | |
$84,871,118 | 57 | 17.71% | $412.59M | |
$24,384,691 | 42 | -30.27% | $455.92M | |
$26,923,982 | 20 | -17.22% | $407.13M | |
$6,280,187 | 19 | 6.80% | $474.63M |
Increased Positions | 85 | +84.16% | 20M | +41.7% |
Decreased Positions | 45 | -44.55% | 9M | -18.25% |
New Positions | 38 | New | 8M | New |
Sold Out Positions | 10 | Sold Out | 2M | Sold Out |
Total Postitions | 141 | +39.6% | 58M | +23.45% |
Wellington Management Group Llp | $230,624.00 | 6.05% | 6.66M | -2M | -21.09% | 2024-12-31 |
Janus Henderson Group Plc | $227,512.00 | 5.97% | 6.57M | -2M | -25.02% | 2024-12-31 |
Capital World Investors | $222,854.00 | 5.85% | 6.43M | -1,959 | -0.03% | 2024-12-31 |
Fmr Llc | $189,671.00 | 4.98% | 5.48M | +5M | +749.1% | 2024-12-31 |
Morgan Stanley | $109,703.00 | 2.88% | 3.17M | +1M | +84.73% | 2024-12-31 |
Rtw Investments, Lp | $86,916.00 | 2.28% | 2.51M | +3M | New | 2024-12-31 |
Price T Rowe Associates Inc /Md/ | $81,543.00 | 2.14% | 2.35M | +548,378 | +30.37% | 2024-12-31 |
Bamco Inc /Ny/ | $66,131.00 | 1.74% | 1.91M | +2,568 | +0.14% | 2024-12-31 |
Clearbridge Investments, Llc | $64,529.00 | 1.69% | 1.86M | +989,664 | +113.34% | 2024-12-31 |
Principal Financial Group Inc | $61,069.00 | 1.6% | 1.76M | +2M | New | 2024-12-31 |